Many people rely on Member States to control the symptoms of this disease. Microsoft attacks the central nervous system, and patients suffering from pain and fatigue, loss of vision and hearing and coordination problems. however, thanks to MS research, medications and therapies have been developed to help control these symptoms. Many believe it's only a matter of time before scientists find a cure for multiple sclerosis. in this article we will see the latest advances in research. in the investigation of multiple sclerosis, earnings have been important in defining the role of the immune system in the development of MS lesions. This finding is important because it allows scientists the opportunity to devise ways to modify the immune response. This work is expected to produce a variety of new potential therapies that could cure MS without harmful side effects. Genetic factors related to immune system that predispose an individual to the development of MS have been identified, and may lead to new ways to treat or prevent disease. MRI monitoring multiple sclerosis has proved valuable. Scientists can now see and follow the development of MS lesions in the brain and spinal cord. This is a great help in evaluating new therapies and can speed the process of evaluating new therapies. There are a number of test treatments that can reduce attacks or improve function of damaged nerve fibers. more than a dozen clinical trials testing potential therapies are underway, and new treatments have been developed and tested in animal models. Of multiple sclerosis in the news, bio pharmaceutical company MediciNova inc. announced data from a double-blind analysis in the first year of treatment from two-year phase II clinical study of MN-166 in multiple sclerosis . The second year of phase II clinical trial in progress with results expected in April 2008. The analysis showed that MN-166 decreased the formation of brain lesions believed to indicate the death of the nerves in the brain on MRI in MS patients. Treatment with 30 mg / day dosing regimen of MN-166 showed a trend towards reduced risk of new lesion evolution to persistent black holes compared to placebo. This means that when diagnosed early, patients can avoid the symptoms of MS. While great strides in the search for MS have been made, much remains to be done. If you have MS and wants to support multiple sclerosis research, the human brain and cerebrospinal fluid Resource Center of Los Angeles requiring tissues of patients with neurological disorders and others to do their studies. The tissue of people with MS is needed to allow scientists to study this disorder more intensely. For those who do not have MS, the best way to help both with financial donations. with this joint effort, maybe some day a world without MS.

Incoming search terms for the article:clinical testing (1),latest monitoring multiple sclerosis research (1),Latest Multiple Sclerosis Tips (1),latest research about nervous system (1),MN-166 (1),multiple sclerosis (1)